We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Simultaneous Mutations Underlie Ovarian Cancer in Mouse Model

By LabMedica International staff writers
Posted on 11 Feb 2015
Print article
Image: Clusters of ovarian clear cell carcinoma due to mutations in the genes ARID1A and PIK3CA (Photo courtesy of Dr. Ron Chandler, University of North Carolina).
Image: Clusters of ovarian clear cell carcinoma due to mutations in the genes ARID1A and PIK3CA (Photo courtesy of Dr. Ron Chandler, University of North Carolina).
Studies carried out on a mouse model of human ovarian clear-cell carcinoma (OCCC) showed that simultaneous mutations in two genes were required to stimulate tumor development.

OCCC is an aggressive form of ovarian cancer with high ARID1A (AT-rich interactive domain-containing protein 1A) mutation rates. However, a novel OCCC mouse model developed by investigators at the University of North Carolina (Chapel Hill, USA) showed that ARID1A inactivation alone was not sufficient for tumor formation. In addition to the ARID1A mutation, concurrent activation of the phosphoinositide 3-kinase catalytic subunit PIK3CA was also required.

Mice with these mutations developed highly penetrating tumors with OCCC-like histopathology, culminating in hemorrhagic ascites and a median survival period of 7.5 weeks. Furthermore, results published in the January 27, 2015, online edition of the journal Nature Communications revealed that ARID1A and PIK3CA mutations cooperated to promote tumor growth through sustained IL-6 (Interleukin-6) overproduction. IL-6 is a cytokine linked to cell signaling that triggers inflammation.

Treatment of OCCC animals with the pan-PI3K inhibitor, BKM120, prolonged mouse survival by inhibiting the tumor cell growth.

“It is an extremely aggressive model of the disease, which is how this form of ovarian cancer presents in women,” said senior author Dr. Terry Magnuson, professor of genetics at the University of North Carolina. “We think that IL-6 contributes to ovarian clear cell carcinoma and could lead to death. You really do not want this cytokine circulating in your body.”

Related Links:

University of North Carolina


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Automated Blood Typing System
IH-500 NEXT
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab
New
Silver Member
Apolipoprotein A-I Assay
Apo A-I Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.